(ENSG) The Ensign - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29358P1012

ENSG: Nursing Homes, Rehabilitation Services, Senior Living Facilities, Pharmacy Services

The Ensign Group, Inc. is a healthcare services company that operates a diverse range of facilities, including skilled nursing, senior living, and rehabilitative care centers. Through its Skilled Services segment, the company provides specialized care to patients with chronic conditions, prolonged illnesses, and elderly individuals, offering a broad spectrum of services such as on-site dialysis, ventilator care, cardiac and pulmonary management, as well as standard services like room and board, nutritional programs, and social activities. Additionally, the company's skilled nursing facilities offer rehabilitation therapy services, catering to the complex needs of patients requiring post-acute care.

The company's Standard Bearer segment, on the other hand, focuses on real estate investments, owning and leasing properties to skilled nursing and senior living operators. This strategic approach enables The Ensign Group to diversify its revenue streams and capitalize on the growing demand for healthcare services. Furthermore, the company provides a range of ancillary services, including digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory care, long-term care pharmacy, and patient transportation, which can be accessed by individuals in their homes or at long-term care facilities. The Ensign Group also offers mobile diagnostics, enhancing the accessibility and convenience of its healthcare services.

With operations spanning across 13 states, including Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin, The Ensign Group has established a significant presence in the US healthcare market. Founded in 1999 and headquartered in San Juan Capistrano, California, the company has evolved into a prominent player in the healthcare services sector, with a strong focus on delivering high-quality, patient-centered care. As a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol ENSG, The Ensign Group is committed to creating long-term value for its shareholders while making a positive impact on the lives of its patients and communities.

Additional Sources for ENSG Stock

ENSG Stock Overview

Market Cap in USD 7,676m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 2007-11-09

ENSG Stock Ratings

Growth 5y 93.8%
Fundamental 52.1%
Dividend 51.3%
Rel. Strength Industry 462
Analysts 4.5/5
Fair Price Momentum 147.61 USD
Fair Price DCF 87.19 USD

ENSG Dividends

Dividend Yield 12m 0.17%
Yield on Cost 5y 0.55%
Annual Growth 5y 3.68%
Payout Consistency 97.7%

ENSG Growth Ratios

Growth Correlation 3m -91%
Growth Correlation 12m 73.9%
Growth Correlation 5y 92.4%
CAGR 5y 25.80%
CAGR/Mean DD 5y 2.73
Sharpe Ratio 12m 0.71
Alpha -3.90
Beta 0.84
Volatility 22.04%
Current Volume 332.2k
Average Volume 20d 376k
What is the price of ENSG stocks?
As of January 22, 2025, the stock is trading at USD 139.33 with a total of 332,169 shares traded.
Over the past week, the price has changed by +4.37%, over one month by +4.14%, over three months by -5.64% and over the past year by +18.83%.
Is The Ensign a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, The Ensign (NASDAQ:ENSG) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 52.10 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENSG as of January 2025 is 147.61. This means that ENSG is currently overvalued and has a potential downside of 5.94%.
Is ENSG a buy, sell or hold?
The Ensign has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy ENSG.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ENSG stock price target?
According to ValueRays Forecast Model, ENSG The Ensign will be worth about 163 in January 2026. The stock is currently trading at 139.33. This means that the stock has a potential upside of +16.96%.
Issuer Forecast Upside
Wallstreet Target Price 169.5 21.7%
Analysts Target Price 112.2 -19.5%
ValueRay Target Price 163 17%